165 related articles for article (PubMed ID: 30724668)
21. The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer.
Li Destri G; Maugeri A; Ramistella A; La Greca G; Conti P; Trombatore G; Vecchio GM; Magro GG; Barchitta M; Agodi A
Updates Surg; 2020 Sep; 72(3):793-800. PubMed ID: 32632764
[TBL] [Abstract][Full Text] [Related]
22. Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer.
Mehraj A; Baba AA; Khan B; Khan MA; Wani RA; Parray FQ; Chowdri NA
J Cancer Res Ther; 2022 Dec; 18(Supplement):S391-S396. PubMed ID: 36510993
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Lin H; Wang L; Zhong X; Zhang X; Shao L; Wu J
World J Surg Oncol; 2021 May; 19(1):141. PubMed ID: 33952287
[TBL] [Abstract][Full Text] [Related]
24. Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma.
Levolger S; van Vledder MG; Alberda WJ; Verhoef C; de Bruin RWF; IJzermans JNM; Burger JW
Clin Nutr; 2018 Oct; 37(5):1728-1735. PubMed ID: 28756039
[TBL] [Abstract][Full Text] [Related]
25. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients: a randomised controlled trial (The EMPOWER Trial).
Loughney L; West MA; Moyses H; Bates A; Kemp GJ; Hawkins L; Varkonyi-Sepp J; Burke S; Barben CP; Calverley PM; Cox T; Palmer DH; Mythen MG; Grocott MPW; Jack S;
Perioper Med (Lond); 2021 Jun; 10(1):23. PubMed ID: 34154675
[TBL] [Abstract][Full Text] [Related]
26. Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial.
Moug SJ; Barry SJE; Maguire S; Johns N; Dolan D; Steele RJC; Buchan C; Mackay G; Anderson AS; Mutrie N
Tech Coloproctol; 2020 Sep; 24(9):959-964. PubMed ID: 32564236
[TBL] [Abstract][Full Text] [Related]
27. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
28. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
29. A lower cut-off for lymph node harvest predicts for poorer overall survival after rectal surgery post neoadjuvant chemoradiotherapy.
Yeo CS; Syn N; Liu H; Fong SS
World J Surg Oncol; 2020 Mar; 18(1):58. PubMed ID: 32197615
[TBL] [Abstract][Full Text] [Related]
30. [The value of MRI with CUBE sequence in early evaluation of the efficacy of neoadjuvant therapy for locally advanced rectal cancer].
Wang X; Cao W; Liu D; Li F; Li W; Kang L; Deng Y; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):73-78. PubMed ID: 29354903
[TBL] [Abstract][Full Text] [Related]
31. Physical activity levels in locally advanced rectal cancer patients following neoadjuvant chemoradiotherapy and an exercise training programme before surgery: a pilot study.
Loughney L; West MA; Dimitrov BD; Kemp GJ; Grocott MP; Jack S
Perioper Med (Lond); 2017; 6():3. PubMed ID: 28228938
[TBL] [Abstract][Full Text] [Related]
32. Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial.
Morielli AR; Boulé NG; Usmani N; Tankel K; Joseph K; Severin D; Fairchild A; Nijjar T; Courneya KS
J Cancer Surviv; 2023 Aug; 17(4):1171-1183. PubMed ID: 34841461
[TBL] [Abstract][Full Text] [Related]
33. The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.
Bohlok A; Hendlisz A; Bouazza F; Galdon MG; Van de Stadt J; Moretti L; El Nakadi I; Liberale G
Int J Colorectal Dis; 2018 Oct; 33(10):1383-1391. PubMed ID: 29984385
[TBL] [Abstract][Full Text] [Related]
34. Comparable regional therapeutic effects between neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy for locally advanced lower rectal cancer in terms of histopathological analysis.
Sato K; Miura T; Morohashi S; Sakamoto Y; Morohashi H; Yoshida T; Hakamada K
Mol Clin Oncol; 2019 Jun; 10(6):619-624. PubMed ID: 31031978
[TBL] [Abstract][Full Text] [Related]
35. [Short-Term Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer].
Sakamoto Y; Kurebayashi H; Sakamoto S; Matsunaka T; Maegawa N; Shimada M; Tagai N; Sawai K; Morikawa M; Koneri K; Tamaki M; Murakami M; Hirono Y; Goi T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1762-1764. PubMed ID: 38303199
[TBL] [Abstract][Full Text] [Related]
36. Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Toomey S; Gunther J; Carr A; Weksberg DC; Thomas V; Salvucci M; Bacon O; Sherif EM; Fay J; Kay EW; Sheehan KM; McNamara DA; Sanders KL; Mathew G; Breathnach OS; Grogan L; Morris PG; Foo WC; You YN; Prehn JH; O'Neill B; Krishnan S; Hennessy BT; Furney SJ
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640573
[TBL] [Abstract][Full Text] [Related]
37. Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: An analysis from the National Cancer Data Base.
Sineshaw HM; Jemal A; Thomas CR; Mitin T
Cancer; 2016 Jul; 122(13):1996-2003. PubMed ID: 27074300
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study.
Del Puerto-Nevado L; Marin-Arango JP; Fernandez-Aceñero MJ; Arroyo-Manzano D; Martinez-Useros J; Borrero-Palacios A; Rodriguez-Remirez M; Cebrian A; Gomez Del Pulgar T; Cruz-Ramos M; Carames C; Lopez-Botet B; Garcia-Foncillas J
BMC Cancer; 2016 Jul; 16():519. PubMed ID: 27456229
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
40. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
